1-4 of 4
Smrithi Ravikumar
Close
Sort by
Journal Articles

High Efficacy and Excellent Safety Profile of Actalycabtagene Autoleucel, a Humanized CD19 CAR-T Product in r/r B-Cell Malignancies: A Phase II Pivotal Trial

Hasmukh Jain, Atharva Karulkar, Devanshi Kalra, Smrithi Ravikumar, Netra Ghandade, Ruchira Patil, Shreshtha Shah, Afrin Firfiray, Juber Pendhari, Rushikesh Patil, Manivasagam S, Neha Sharma, Alok Shetty, Lingaraj Nayak, Bhausaheb Bagal, Shripad Banavali, Gaurav Narula, Preeti Desai, Anisha Navkudkar, Prashant Tembhare, Navin Khattry, Epari Sridhar, Nikhil Patkar, Sumeet Gujral, Tanuja Shet, Uma Sakhadeo, Papagudi Ganesan Subramanian, Jayshree Thorat, Anamika Prashant, Sachin Punatar, Anant Gokarn, Kinjalka Ghosh, Archi Agrawal, Yash Jain, Venkatesh Rangarajan, Shashank Ojha, Shilpushp Bhosle, Siddhartha Laskar, Sangeeta Kakoti, Sumeet Mirgh, Sumathi Hiregoudar, Minal Poojary, Nitin Shetty, Vasundhara Patil, Akshay Baheti, Sanjay Biswas, Gaurav Salunkhe, Kunal Gala, Manju Sengar, Nirali N. Shah, Sattva S. Neelapu, Rahul Purwar
Journal: Blood
Blood (2023) 142 (Supplement 1): 4838.
https://doi.org/10.1182/blood-2023-185507
Published: 2023
Journal Articles

Excellent Safety Profile of a Low-Cost Novel Humanized CD19 CAR T-Cell Therapy, Actalycabtagene Autoleucel : Potential Impact on Access and Feasibility

Atharva Karulkar, Ankesh Kumar Jaiswal, Aalia Khan, Devanshi Kalra, Smrithi Ravikumar, Netra Ghandade, Ruchira Patil, Shreshtha Shah, Afrin Firfiray, Juber Pendhari, Rushikesh Patil, Manivasagam S, Jayshree Thorat, Neha Sharma, Alok Shetty, Thomas Eipe, Lingaraj Nayak, Bhausaheb Bagal, Manju Sengar, Gaurav Narula, Nirali N. Shah, Sattva S. Neelapu, Hasmukh Jain, Rahul Purwar
Journal: Blood
Blood (2023) 142 (Supplement 1): 257.
https://doi.org/10.1182/blood-2023-177594
Published: 2023
Journal Articles

Making Anti-CD19 CAR-T Cell Therapy Accessible and Affordable: First-in-Human Phase I Clinical Trial Experience from India

Atharva Karulkar, Hasmukh Jain, Shreshtha Shah, Aalia Khan, Ankesh Jaiswal, Afrin Firfiray, Prashant Suvasia, Priyanshi Suvasia, Juber Pendhari, Sweety Asija, Ambalika Chowdury, Ankit Banik, Smrithi Ravikumar, Neha Sharma, Minal Poojary, Sumathi Hiregoudar, Preeti Desai, Anisha Navkudkar, Sunil Rajadhyaksha, Jayashree Thorat, Prashant R. Tembhare, Albeena Nisar, Manju Sengar, David F. Stroncek, Steven Highfill, Nirali N. Shah, Gaurav Narula, Rahul Purwar
Journal: Blood
Blood (2022) 140 (Supplement 1): 4610–4611.
https://doi.org/10.1182/blood-2022-168928
Published: 2022
Journal Articles

Phase I Trial of Humanized CD19 CART-Cell Therapy Developed in India: Safe, Active and Feasible for Outpatient Therapy

Hasmukh Jain, Atharva Karulkar, Neha Sharma, Manju Sengar, Ankesh Jaiswal, Shreshtha Shah, Aalia Khan, Afrin Firfiray, Sweety Asija, Prashant Suvasia, Priyanshi Suvasia, Juber Pendhari, Devanshi Kalra, Smrithi Ravikumar, Gaurav Narula, Shripad Banavali, Minal Poojary, Sumathi Hiregoudar, Lingaraj Nayak, Bhausaheb Bagal, Prashant R. Tembhare, Sridhar Epari, Navin Khattry, Nikhil Patkar, Sumeet Gujral, Tanuja Shet, Papagudi Ganesan Subramanian, Jayashree Thorat, Sachin Punatar, Anant Gokarn, Kinjalka Ghosh, Archi Agarwal, Preeti Desai, Shashank Ojha, Subhash Yadav, Shil Pushp Bhosale, Sunil Rajadhyaksha, Anisha Navkudkar, Siddharth Laskar, Sumeet Prakash Mirgh, Albeena Nisar, Deepali Pandit, Ruchira Patil, Rahul Purwar, Sattva S. Neelapu, Nirali N. Shah
Journal: Blood
Blood (2022) 140 (Supplement 1): 10332–10334.
https://doi.org/10.1182/blood-2022-166082
Published: 2022